OrganizationsbioMason

Products 1 to 1 of 1

bioCement by bioMason
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:47 (5 years ago)
Known funding amount: 2,800,000 USD
Funding types: Foundation + Government + University + Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product